机械通气患者中的COVID-19相关肺曲霉病:法国多中心观察性队列(APICOVID)的发病率与结局
该多中心回顾性观察性队列纳入2020年法国15个ICU连续收治的708例需机械通气的成人COVID-19患者,按2020年ECMM/ISHAM共识标准诊断并分级CAPA。主要目标为确定确诊/可能CAPA的发病率,次要目标为识别危险因素并评估其与结局的关联。结果显示可能CAPA 18例(2.5%),无组织学确诊CAPA;年龄较大是唯一与可能CAPA显著相关的因素(HR 1.04;95%CI 1.00-1.09;P=0.04)。可能CAPA与第90天死亡率显著升高相关(HR 2.07;95%CI 1.32-3.25;P=0.001),但与机械通气时间或ICU住院时间延长无关。
要点
- 708例机械通气COVID-19成人中,符合可能CAPA标准者18例(2.5%),无组织学确诊CAPA。
- 年龄较大是唯一与可能CAPA显著相关的因素(HR 1.04;95%CI 1.00-1.09;P=0.04)。
- 可能CAPA与第90天死亡率显著升高相关(HR 2.07;95%CI 1.32-3.25;P=0.001)。
- 可能CAPA与机械通气时间或ICU住院时间延长无显著关联。
- 队列第90天死亡率为28.5%,机械通气中位时长15.0[8.0-27.0]天。
适用人群与场景
- 2020年法国15个ICU连续收治的成人COVID-19需机械通气患者,共708例(男性522例,73.7%),平均年龄65.2±10.8岁。
- 113例(16.0%)存在基础免疫抑制;348例(63.1%)使用糖皮质激素。
诊断标准与关键阈值
- CAPA按2020年ECMM/ISHAM共识标准诊断并分级;可能CAPA 18例(2.5%),无组织学确诊CAPA。
研究设计与关键结果
- 多中心回顾性观察性队列:15个法国ICU,708例机械通气COVID-19成人,主要目标为确诊/可能CAPA发病率。
- 可能CAPA 18例(2.5%),无组织学确诊CAPA;年龄较大是唯一显著相关因素(HR 1.04;95%CI 1.00-1.09;P=0.04)。
- 可能CAPA与第90天死亡率显著升高相关(HR 2.07;95%CI 1.32-3.25;P=0.001),与机械通气时间或ICU住院时间延长无显著关联。
- 队列第90天死亡率28.5%;机械通气中位时长15.0[8.0-27.0]天。
证据类型、等级与局限
- 证据类型:多中心回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在机械通气COVID-19患者中,可能CAPA少见(2.5%)但与第90天死亡率升高相关(HR 2.07),提示对符合2020年ECMM/ISHAM可能CAPA标准者应重视其不良预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Recent studies identified coronavirus disease 2019 (COVID-19) as a risk factor for invasive pulmonary aspergillosis (IPA) but produced conflicting data on IPA incidence and impact on patient outcomes. We aimed to determine the incidence and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) in mechanically ventilated patients.
METHODS: We performed a multicenter retrospective observational cohort study in consecutive adults admitted to 15 French intensive care units (ICUs) in 2020 for COVID-19 requiring mechanical ventilation. CAPA was diagnosed and graded according to 2020 ECMM/ISHAM consensus criteria. The primary objective was to determine the incidence of proven/probable CAPA, and the secondary objectives were to identify risk factors for proven/probable CAPA and to assess associations between proven/probable CAPA and patient outcomes.
RESULTS: The 708 included patients (522 [73.7%] men) had a mean age of 65.2 ± 10.8 years, a median mechanical ventilation duration of 15.0 [8.0-27.0] days, and a day-90 mortality rate of 28.5%. Underlying immunosuppression was present in 113 (16.0%) patients. Corticosteroids were used in 348 (63.1%) patients. Criteria for probable CAPA were met by 18 (2.5%) patients; no patient had histologically proven CAPA. Older age was the only factor significantly associated with probable CAPA (hazard ratio [HR], 1.04; 95% CI 1.00-1.09; P = 0.04). Probable CAPA was associated with significantly higher day-90 mortality (HR, 2.07; 95% CI 1.32-3.25; P = 0.001) but not with longer mechanical ventilation or ICU length of stay.
CONCLUSION: Probable CAPA is a rare but serious complication of severe COVID-19 requiring mechanical ventilation and is associated with higher day-90 mortality.
参考来源
- Desmedt L, Raymond M, Le Thuaut A, et al. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID). Ann Intensive Care. 2024. PMID: 38285382. doi:10.1186/s13613-023-01229-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。